133 related articles for article (PubMed ID: 7477642)
1. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
[TBL] [Abstract][Full Text] [Related]
2. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients.
Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY
Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients.
Durlik M; Gaciong Z; Soluch L; Rancewicz Z; Rowińska D; Kozłowska-Boszko B; Wyzga J; Walewska-Zielecka B; Rowiński W; Szmidt J; Lao M
Ann Transplant; 1996; 1(2):11-2. PubMed ID: 9869922
[TBL] [Abstract][Full Text] [Related]
4. The long-term course of hepatitis C after kidney transplantation.
Kliem V; van den Hoff U; Brunkhorst R; Tillmann HL; Flik J; Manns MP; Pichlmayr R; Koch KM; Frei U
Transplantation; 1996 Nov; 62(10):1417-21. PubMed ID: 8958266
[TBL] [Abstract][Full Text] [Related]
5. Long-term impact of hepatitis B, C virus infection on renal transplantation.
Lee WC; Shu KH; Cheng CH; Wu MJ; Chen CH; Lian JC
Am J Nephrol; 2001; 21(4):300-6. PubMed ID: 11509802
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
8. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation].
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
Presse Med; 1991 Nov; 20(40):2025-7. PubMed ID: 1837117
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic viral hepatitis before and after renal transplantation.
Gane E; Pilmore H
Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
[TBL] [Abstract][Full Text] [Related]
16. The impact of hepatitis C virus infection on liver disease in renal transplant recipients.
Fujimoto N; Kyo M; Ichikawa Y; Fukunishi T; Nagano S
Transpl Int; 1994; 7 Suppl 1():S346-9. PubMed ID: 11271248
[TBL] [Abstract][Full Text] [Related]
17. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
19. HBV and HCV infections in heart transplant recipients.
Fagiuoli S; Minniti F; Pevere S; Farinati F; Burra P; Livi U; Naccarato R; Chiaramonte M
J Heart Lung Transplant; 2001 Jul; 20(7):718-24. PubMed ID: 11448796
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
